Indivior Pharmaceuticals, Inc. (INDV) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US45579U1097
Indivior Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.24 bn USD |
| Gross profit | 994.00 m USD |
| Operating income | 262.00 m USD |
| EBIT | 262.00 m USD |
| Net income | 210.00 m USD |
| Diluted EPS – continuing operations | 1.64 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
More stocks
- KILROY REALTY CORP (KRC)
- Tangshan Port Group Co Ltd (601000.SS)
- China Nuclear Engineering Co (601611.SS)
- Grupo Simec S.A.B. de C.V (SIMECB.MX)
- Red Avenue New Materials Group Co Ltd (603650.SS)
- VALVOLINE INC (VVV)
- FIRST BANCORP /PR/ (FBP)
- Volvo Car AB (VOLCAR B.ST)
- RENK Group (R3NK.DE)
- KORN FERRY (KFY)
- Dmg Mori (GIL.DE)
- VSE CORP (VSEC)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.